Intuitive Surgical (ISRG) Analysis Market Leadership:
Intuitive Surgical NASDAQ:ISRG , the leader in robotic-assisted surgery with its da Vinci system, is poised for substantial growth. The increasing adoption of robotic surgeries, currently under 5% of potential procedures, presents a significant opportunity. Additionally, the aging global population boosts demand for minimally invasive surgeries, favoring Intuitive Surgical's market position.
Analyst Projections:
Analysts project a median upside of 13% to 25% over the next year. For investors seeking steady returns and a strong healthcare business with a solid competitive moat, ISRG is an excellent choice.
Investment Outlook:
Bullish Outlook: We are bullish on ISRG above the $350.00-$355.00 range.
Upside Potential: With a target set at $540.00-$550.00, key growth drivers include the ongoing adoption of robotic surgeries and favorable demographic trends.
📊🤖 Monitor Intuitive Surgical for promising investment opportunities! #ISRG #RoboticSurgery 📈💼
Roboticsurgery
Using $TRXC info to guide $TMDI decisionNASDAQ:TMDI
AMEX:TRXC
These symbols have been on a similar path throughout the year. From November to the beginning of January, $TRXC price action lagged a few days behind $TMDI. Since January $TMDI appears to be the follower. Watching price action of $TRXC when it reaches the yellow ellipse may give us an idea of how $TMDI will eventually exit this channel. May be a good spot for a short-term swing trade.
Thanks for looking!
Titan Medical - Surgical Robots and their Huge potentialJohnson & Johnson recently bought Auris Health for $3.4bn -World’s largest healthcare group tries to speed up move into digital surgery
TMD would have a share price of $175 for all outstanding shares with a similar Market Cap of $3.5 billion.
AND..... The original Surgical Robot developed by Intuitive Surgical The DaVinci
Intuitive Surgical Inc Market Cap: 62.97B which would give TMD shares a value of $2900 (Bare with me if it seems a little extreme comparison, but ISRG was founded in 2005 with a starting share price of $21.40, currently trades at $550 and US$ 3,1 billion revenue (2017) while the company focuses on a single robot )
Titan has a large number of patents across China, Europe, USA. It also has partners in place to do business in all three, so it has a huge market potential. The company says its SPORT surgical system has benefits over DaVinci.... Smaller, more maneuverable, more disposable, more attainable in terms of affordability. Founded by six surgeons who thought they could do better.... :)
You can read for yourself if you're interested.. titanmedicalinc.com
We are truly moving into the robot age....
www.zerohedge.com